Ro 41-0960 is a reversible and orally -active COMT-inhibitor. References: Gálvez-Llompart M, Recio MC, García-Domenech R, Gálvez J. Molecular topology: a strategy to identify novel compounds against ulcerative colitis. Mol Divers. 2017 Feb;21(1):219-234. doi: 10.1007/s11030-016-9706-7. Epub 2016 Oct 12. PubMed PMID: 27734189.

纯度：≥98%

CAS：125628-97-9